N-Ethylhexedrone was patented by the German pharmaceutical business Boehringer Ingelheim in 1964 as a potential anorexigenic agent. The patent describes its synthesis together with other derivatives of aminoketone.[one] copyright - Any neurotoxic effects of copyright are more likely to be ele